The Clinical Presentation and Factors Associated with Disease Severity of Rheumatoid Arthritis in Uganda: A Cross-Sectional Study

References

• Smolen JS, Landewe RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79(6):685–699. doi:10.1136/annrheumdis-2019-216655
   PubMed Web of Science ®Google Scholar
• van Dongen H, van Aken J, Lard LR, et al. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 2007;56(5):1424–1432. doi:10.1002/art.22525
   PubMed Web of Science ®Google Scholar
• World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity; 2011.
   Google Scholar
• World Health Organization. Obesity and overweight. Fact Sheet No 3112013; 2021.
   Google Scholar
• Pincus TSJ, Soraci SA Jr, Wallston KA, Hummon NP, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum. 1983;26:1346–1353. doi:10.1002/art.1780261107
   PubMed Web of Science ®Google Scholar
• Hewlett S, Kirwan J, Bode C, et al. The revised Bristol Rheumatoid Arthritis Fatigue measures and the rheumatoid arthritis impact of disease scale: validation in six countries. Rheumatology. 2018;57(2):300–308. doi:10.1093/rheumatology/kex370
   PubMed Web of Science ®Google Scholar
• Prevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44–48. doi:10.1002/art.1780380107
   PubMed Web of Science ®Google Scholar
• Fransen J, Van Riel P. The Disease Activity Score and the EULAR response criteria. Clin Exp Rheumatol. 2005;23(5):S93.
   PubMed Web of Science ®Google Scholar
• Uganda Bureau of Statistics (UBOS), 2018. Uganda National Household Survey 2016/2017. Kampala, Uganda, UBOS. Available from: https://www.ubos.org/wp-content/uploads/publications/03_20182016_UNHS_FINAL_REPORT.pdf. Accessed April 29, 2022.
   Google Scholar
• Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423(6937):356–361. doi:10.1038/nature01661
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. New therapies for treatment of rheumatoid arthritis. Lancet. 2007;370(9602):1861–1874. doi:10.1016/S0140-6736(07)60784-3
   PubMed Web of Science ®Google Scholar
• Kanyerezi BR, Lutalo SK. Some aspects of rheumatoid disease in Uganda. East Afr Med J. 1980;57(1):39–43.
   PubMed Web of Science ®Google Scholar
• Fleming A, Benn RT, Corbett M, Wood PH. Early rheumatoid disease. II. Patterns of joint involvement. Ann Rheum Dis. 1976;35(4):361–364. doi:10.1136/ard.35.4.361
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–2581. doi:10.1002/art.27584
   PubMed Web of Science ®Google Scholar
• Bagg LR, Hansen DP, Lewis C, Houba V. Rheumatoid arthritis in Kenya. I. Clinical observations. Ann Rheum Dis. 1979;38(1):23–25. doi:10.1136/ard.38.1.23
   PubMed Web of Science ®Google Scholar
• Ouedraogo DD, Singbo J, Diallo O, Sawadogo SA, Tieno H, Drabo YJ. Rheumatoid arthritis in Burkina Faso: clinical and serological profiles. Clin Rheumatol. 2011;30(12):1617–1621. doi:10.1007/s10067-011-1831-1
   PubMed Web of Science ®Google Scholar
• Ndongo S, Lekpa FK, Ka MM, Ndiaye N, Diop TM. Presentation and severity of rheumatoid arthritis at diagnosis in Senegal. Rheumatology. 2009;48(9):1111–1113. doi:10.1093/rheumatology/kep178
   PubMed Web of Science ®Google Scholar
• Yazici Y, Pincus T, Kautiainen H, Sokka T. Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate. J Rheumatol. 2004;31(9):1723–1726.
   PubMed Web of Science ®Google Scholar
• Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD, Tanasescu R. Extra-articular Manifestations in Rheumatoid Arthritis. Maedica. 2010;5(4):286–291.
   PubMedGoogle Scholar
• Richman NC, Yazdany J, Graf J, Chernitskiy V, Imboden JB. Extraarticular manifestations of rheumatoid arthritis in a multiethnic cohort of predominantly Hispanic and Asian patients. Medicine. 2013;92(2):92–97. doi:10.1097/MD.0b013e318289ce01
   PubMed Web of Science ®Google Scholar
• Ohagwu KOH, Oba R, Adelowo O. Pattern of rheumatoid arthritis in Nigeria; study of patients from a teaching hospital. Afr j Rheumatol. 2017;5(2):45–49.
   Google Scholar
• Wolfe F, Hawley DJ, Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol. 1996;23(8):1407–1417.
   PubMed Web of Science ®Google Scholar
• Versteeg GA, Steunebrink LMM, Vonkeman HE, Ten Klooster PM, van der Bijl AE, van de Laar M. Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practice. Clin Rheumatol. 2018;37(5):1189–1197. doi:10.1007/s10067-017-3962-5
   PubMed Web of Science ®Google Scholar
• Kimsey L, Weissman JS, Patel A, Drew A, Koehlmoos T, Sparks JA. Delay in initiation of DMARD or anti-inflammatory therapy in patients newly diagnosed with rheumatoid arthritis: an analysis of United States Military Health System TRICARE beneficiaries. Semin Arthritis Rheum. 2019;48(5):821–827. doi:10.1016/j.semarthrit.2018.07.003
   PubMed Web of Science ®Google Scholar
• Benaglio F, Fornaro M, Montecucco C, et al. Methotrexate in Italian patients wiTh Rheumatoid Arthritis (MITRA study): an observational study about the use of methotrexate in early RA patients and the adherence to the EULAR 2013 recommendations. A project of the Italian Society for Rheumatology. Clin Exp Rheumatol. 2021;39(5):1077–1084.
   PubMed Web of Science ®Google Scholar
• Niasse M, Kane BS, Ndiaye AA, et al. Severity of the rheumatoid arthritis in Sub-Saharan Africa: study of 403 senegalese observations. Open J Intern Med. 2017;7(04):151. doi:10.4236/ojim.2017.74016
   Google Scholar
• Malemba JJ, Mbuyi-Muamba JM, Mukaya J, Bossuyt X, Verschueren P, Westhovens R. The epidemiology of rheumatoid arthritis in Kinshasa, Democratic Republic Of Congo—a population-based study. Rheumatology. 2012;51(9):1644–1647. doi:10.1093/rheumatology/kes092
   PubMed Web of Science ®Google Scholar
• Combe B, Landewé R, Lukas C, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007;66(1):34–45. doi:10.1136/ard.2005.044354
   PubMed Web of Science ®Google Scholar
• Lukas C, Combe B, Ravaud P, Sibilia J, Landew R, Van Der Heijde D. Favorable effect of very early disease‐modifying antirheumatic drug treatment on radiographic progression in early inflammatory arthritis: data from the Étude et Suivi des Polyarthrites IndifféRenciées récentes (study and followup of early undifferentiated polyarthritis). Arthritis Rheum. 2011;63(7):1804–1811.
   PubMed Web of Science ®Google Scholar
• Altinkesen E, Gelecek N. Functional status and quality of life in patients with early and late stage rheumatoid arthritis. Fiz Rehabil. 2011;22(2):93–99.
   Google Scholar
• Glave-Testino C, Cardiel M, Arce-Salinas A, Alarcon-Segovia D. Factors associated with disease severity in Mexican patients with rheumatoid arthritis. Clin Exp Rheumatol. 1994;12(6):589–594.
   PubMed Web of Science ®Google Scholar
• Naeem F, Khan SEA, Saeed MA, Farman S. Diagnostic and therapeutic delay in Rheumatoid Arthritis patients: impact on disease outcome. Pak J Med Sci. 2021;37(4):1001–1007. doi:10.12669/pjms.37.4.3471
   PubMed Web of Science ®Google Scholar
• Anderson JJ, Wells G, Verhoeven AC, Felson DT. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum. 2000;43(1):22–29. doi:10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9
   PubMed Web of Science ®Google Scholar